Have You or a Loved One Suffered from Fournier’s Gangrene After Taking Xigduo?
If you or someone you know has suffered from Fournier’s Gangrene while taking Type 2 diabetes medications such as Xigduo, you may be entitled to financial compensation.
Our attorneys at Cory Watson are investigating drug injury claims nationwide. Don’t wait to reach out – your health may be on the line.
DANGEROUS SIDE-EFFECTS LINKED TO XIGDUO
Adults with Type 2 diabetes rely on prescription drugs like Xigduo or its counterpart, Farxiga, to help lower their blood sugar. They are part of a class of drugs known as SGLT2 inhibitors. However, some patients are reporting serious injuries after taking the medications.
In August 2018, the FDA warned that medications made from SGLT2 inhibitors have been linked to a rare but serious infection of the genitals. This condition is called necrotizing fascitis of the perineum, also known as Fournier’s Gangrene.
Other Type 2 diabetes drugs that may be linked to gangrene include:
Compensation from a Xigduo Lawsuit
The unexpected tragedy of a serious infection can be life-changing. We understand that you may be facing costly surgical procedures or complete lifestyle changes.
An experienced Xigduo lawsuit attorney will advocate for you to receive financial compensation to help pay for:
- Past and present medical expenses
- Lost income due to missed work
- Home renovations such as wheelchair access
- In-home treatment or physical therapy
- Emotional trauma and suffering
Call today and find out what you are owed for your losses. You don’t pay unless we win your case, but the time to claim compensation is limited.
CONTACT OUR EXPERIENCED XIGDUO ATTORNEYS
Cory Watson Attorneys has recovered more than $3 Billion for clients across the United States, and we’re ready to fight for you.
Our attorneys are investigating Xigduo lawsuits across the country on behalf of victims who experienced harmful side effects while taking SGLT2 inhibitor diabetes medications.
Call (877) 562-0000 or complete a free initial consultation form on this page to get help now.
Invokana® and Invokamet® are registered trademarks of Janssen Pharmaceuticals, Inc., and are used here only to identify the products in question. Farxiga® and Xigduo XR® are registered trademarks of Astrazeneca, plc, and are used here only to identify the products in question. Jardiance® and Glyxambi® are registered trademarks of Boehringer Ingelheim Pharmaceuticals, Inc., and are used here only to identify the products in question.
This law firm is not associated with, sponsored by, or affiliated with AstraZeneca plc; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceticals, Inc.; or the U.S. Food and Drug Administration.